Motivational interviewing to improve diabetes self-management and reduce cyberchondria

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of motivational interviewing techniques in enhancing diabetes self-management and reducing the severity of cyberchondria among individuals with Type 2 diabetes. A total of 64 participants will be divided into an experimental group receiving weekly motivational interviewing sessions for one month and a control group. The study will utilize the Diabetes Self-Management Scale and the Cyberchondria Severity Scale-Short Form to assess outcomes before and after the intervention. Conducted at the Van Regional Training and Research Hospital, the research will take place from February to March 2025.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Having diabetes for at least 6 months
* Being over 18 years old
* To have sufficient communication skills to answer verbal and written questions and fulfill instructions
* Being literate
* No physical, cognitive or mental impairment in answering the questions
* Willingness to participate in research.

Exclusion Criteria:

* Being under 18 years of age
* Being hospitalized in inpatient treatment institutions due to DM or DM complications during the research process
* The emergence of any health problem that prevents the person from continuing the research
* Do not leave the study voluntarily.

Where it's running

• Van Regional Training and Research Hospital Diabetes Polyclinic
  Van, Van, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Gülşen ALTUNTAŞ ÇALIM, PhD student
• Email: gulsenaltuntas13@hotmail.com
• Phone: +905535383055

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.